IGF1 and Hyperinsulinemia: High insulin levels in hyperinsulinemia activate insulin/IGF signaling pathways followed by the activation of (PI3K)/Akt/mammalian rapamycin (mTOR) and MAPK signaling pathways, thus promoting cancer cell growth, survival, and mobility [72,73].